Literature DB >> 24290088

Prevalence of the metabolic syndrome and its correlation with the cardiovascular health status in stroke- and ischemic heart disease-free Ecuadorian natives/mestizos aged ≥40 years living in Atahualpa: a population-based study.

Oscar H Del Brutto1, Mauricio Zambrano, Ernesto Peñaherrera, Martha Montalván, Freddy Pow-Chon-Long, Daniel Tettamanti.   

Abstract

AIMS: Epidemiologic studies assessing cardiovascular risk factors affecting a given population may prove cost-effective to reduce the burden of cardiovascular diseases in the developing world. We evaluated the prevalence of the metabolic syndrome in Atahualpa, a village representative of rural coastal Ecuador.
METHODS: Prevalence of the metabolic syndrome and its correlation with the cardiovascular (CVH) status was assessed in a door-to-door survey performed in stroke- and ischemic heart disease-free Ecuadorian native/mestizos aged ≥40 years.
RESULTS: The metabolic syndrome was diagnosed in 288 (55.7%) out of 517 persons. Worst individual components were: increased waist circumference (75%), increased fasting glucose (68.1%) and high blood pressure (56.5%). Prevalence of individual components of this condition varied according to age, gender, education, and alcohol intake. However, no differences were found in the odds for having the metabolic syndrome when persons were stratified according to these parameters. A poor CVH status was found in 80.2% persons with and in 55.9% without the metabolic syndrome (p<0.0001).
CONCLUSIONS: Prevalence of the metabolic syndrome in Atahualpa is high. Most persons with the metabolic syndrome also have a poor CVH status. However, sizable subsets only have either the metabolic syndrome or a poor CVH status. Stratification of cardiovascular risk according to whether the person has both, one, or none of these two sets of risk factors would be of value to evaluate if the metabolic syndrome, a poor CVH status or the combination of both, better predict the occurrence of vascular outcomes in the long-term follow-up.
Copyright © 2013 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atahualpa; Cardiovascular health status; Cardiovascular risk; Ecuador; Epidemiology; Metabolic syndrome

Mesh:

Substances:

Year:  2013        PMID: 24290088     DOI: 10.1016/j.dsx.2013.10.006

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  5 in total

Review 1.  Obesity, Diabetes, and Other Cardiovascular Risk Factors in Native Populations of South America.

Authors:  Roberto A Ingaramo
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

2.  Prevalence of metabolic syndrome: association with risk factors and cardiovascular complications in an urban population.

Authors:  Gisela Cipullo Moreira; José Paulo Cipullo; Luiz Alberto Souza Ciorlia; Cláudia Bernardi Cesarino; José Fernando Vilela-Martin
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

3.  Association of high-density lipoprotein with development of metabolic syndrome components: a five-year follow-up in adults.

Authors:  Xiangtong Liu; Lixin Tao; Kai Cao; Zhaoping Wang; Dongning Chen; Jin Guo; Huiping Zhu; Xinghua Yang; Youxin Wang; Jingjing Wang; Chao Wang; Long Liu; Xiuhua Guo
Journal:  BMC Public Health       Date:  2015-04-22       Impact factor: 3.295

Review 4.  Lifestyle Modification in the Management of Metabolic Syndrome: Statement From Korean Society of CardioMetabolic Syndrome (KSCMS).

Authors:  Hack-Lyoung Kim; Jaehoon Chung; Kyung-Jin Kim; Hyun-Jin Kim; Won-Woo Seo; Ki-Hyun Jeon; Iksung Cho; Jin Joo Park; Min-Ho Lee; Jon Suh; Sang-Yup Lim; Seonghoon Choi; Sang-Hyun Kim
Journal:  Korean Circ J       Date:  2022-02       Impact factor: 3.243

5.  Reasons for Declining Consent in a Population-Based Cohort Study Conducted in a Rural South American Community.

Authors:  Oscar H Del Brutto; Pablo R Castillo; Mark J Sedler; Victor J Del Brutto; Mauricio Zambrano; Robertino M Mera; Clinton B Wright; Tatjana Rundek
Journal:  J Environ Public Health       Date:  2018-11-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.